It's an open book—pharma companies pay massive fees to regulatory authorites
See the price lists here...
None of this is secret
Subscribers may not know that the funding of the pharmaceutical regulatory authorities is an open book, in the sense that the price lists appear
Keep reading with a 7-day free trial
Subscribe to INSIDE PHARMA to keep reading this post and get 7 days of free access to the full post archives.